Search Results Search Sort by RelevanceMost Recent Viewpoint Jun 2012 What Can Physicians Learn from the Neurodiversity Movement? Christina Nicolaidis, MD, MPH The neurodiversity movement challenges us to rethink autism through the lens of human diversity, valuing diversity in neurobiologic development as we would value it in gender, race, ethnicity, religion, or sexual orientation. Virtual Mentor. 2012;14(6):503-510. doi: 10.1001/virtualmentor.2012.14.6.oped1-1206. Policy Forum Mar 2018 Who Counts? What Counts? Place and the Limits of Perinatal Mortality Measures Claire Wendland, MD, PhD Perinatal mortality indicators like the maternal mortality ratio mask social determinants of health and undermine reproductive justice. AMA J Ethics. 2018;20(3):278-287. doi: 10.1001/journalofethics.2018.20.3.pfor2-1803. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038.